rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Christina Rossi

Director

Company insider

Files Form 4 as: Director, CG Oncology; Chief Operating Officer, Blueprint Medicines; Director, Xilio Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
66
Buys
0
Sells
18
Bought
$0
Sold
$3.4M
Companies
3
Companies where not an officer
2
First trade
1 Nov 2018
Last trade
4 Jun 2026
Last filed
5 Jun 2026

Companies traded

Where they are an officer
Blueprint MedicinesOfficer · last 17 Jul 20250 buys · 18 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CGON CG OncologyDirector · Biotechnology · last 4 Jun 20260 buys · 0 sells
XLO Xilio TherapeuticsDirector · Biotechnology · last 11 Jun 20250 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Jun 2026filed 5 Jun 2026CGON CG Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—9,354 at $0.00filing
4 Jun 2026filed 5 Jun 2026CGON CG Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—9,354 at $0.00filing
24 Nov 2025filed 26 Nov 2025CGON CG Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—20,889 at $0.00filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—80,000filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—6,500filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—28,500filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—26,125filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—30,000filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—30,000filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—30,000filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—26,400filing
17 Jul 2025filed 21 Jul 2025Blueprint MedicinesSEC FORM 4 Code A—39,456filing
17 Jul 2025filed 21 Jul 2025Blueprint MedicinesSEC FORM 4 Code D—82,374filing
17 Jul 2025filed 21 Jul 2025Blueprint MedicinesSEC FORM 4 Code U—20,628filing
3 Jul 2025filed 8 Jul 2025Blueprint MedicinesSEC FORM 4 Sold$150K1,172 at $128.25filing
11 Jun 2025filed 12 Jun 2025XLO Xilio Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—31,000 at $0.00filing
19 May 2025filed 21 May 2025Blueprint MedicinesSEC FORM 4 Sold$81K804 at $100.14filing
19 May 2025filed 21 May 2025Blueprint MedicinesSEC FORM 4 Sold$142K1,413 at $100.67filing
19 May 2025filed 21 May 2025Blueprint MedicinesSEC FORM 4 Sold$5,79857 at $101.72filing
5 May 2025filed 7 May 2025Blueprint MedicinesSEC FORM 4 Sold$61K607 at $100.97filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed18

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.